According to Sun Pharmaceutical 's latest financial reports the company's current earnings (TTM) are $1.27 B. In 2022 the company made an earning of $0.61 B a decrease over its 2021 earnings that were of $1.00 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $1.27 B | 108.25% |
2022 | $0.61 B | -39.23% |
2021 | $1.00 B | 192.54% |
2020 | $0.34 B | -53.06% |
2019 | $0.73 B | 10.82% |
2018 | $0.66 B | 22.21% |
2017 | $0.54 B | -62.79% |
2016 | $1.45 B | 86.94% |
2015 | $0.77 B | -36.97% |
2014 | $1.23 B | 79.44% |
2013 | $0.68 B | -10.61% |
2012 | $0.76 B |